- Home
- CCIRW vs FBIOP Comparison
CCIRW vs FBIOP Comparison
Compare CCIRW & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIRW
- FBIOP
- Stock Information
- Founded
- CCIRW 2021
- FBIOP N/A
- Country
- CCIRW United States
- FBIOP United States
- Employees
- CCIRW N/A
- FBIOP 101
- Industry
- CCIRW
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- CCIRW
- FBIOP Health Care
- Exchange
- CCIRW Nasdaq
- FBIOP Nasdaq
- Market Cap
- CCIRW N/A
- FBIOP N/A
- IPO Year
- CCIRW N/A
- FBIOP N/A
- Fundamental
- Price
- CCIRW $1.80
- FBIOP $9.47
- Analyst Decision
- CCIRW
- FBIOP
- Analyst Count
- CCIRW 0
- FBIOP 0
- Target Price
- CCIRW N/A
- FBIOP N/A
- AVG Volume (30 Days)
- CCIRW 49.8K
- FBIOP N/A
- Earning Date
- CCIRW 02-18-2025
- FBIOP N/A
- Dividend Yield
- CCIRW N/A
- FBIOP N/A
- EPS Growth
- CCIRW N/A
- FBIOP N/A
- EPS
- CCIRW N/A
- FBIOP N/A
- Revenue
- CCIRW N/A
- FBIOP N/A
- Revenue This Year
- CCIRW N/A
- FBIOP N/A
- Revenue Next Year
- CCIRW N/A
- FBIOP N/A
- P/E Ratio
- CCIRW N/A
- FBIOP N/A
- Revenue Growth
- CCIRW N/A
- FBIOP N/A
- 52 Week Low
- CCIRW $0.19
- FBIOP N/A
- 52 Week High
- CCIRW $1.64
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- CCIRW N/A
- FBIOP 85.14
- Support Level
- CCIRW N/A
- FBIOP $6.43
- Resistance Level
- CCIRW N/A
- FBIOP $7.00
- Average True Range (ATR)
- CCIRW 0.00
- FBIOP 0.41
- MACD
- CCIRW 0.00
- FBIOP 0.25
- Stochastic Oscillator
- CCIRW 0.00
- FBIOP 99.37
About CCIRW Cohen Circle Acquisition Corp. I Warrant
Cohen Circle Acquisition Corp I is a blank check company.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.